TY - JOUR
T1 - Development of ileal adenomas after ileal pouch-anal anastomosis versus end ileostomy in patients with familial adenomatous polyposis
AU - Aelvoet, Arthur S.
AU - Roos, Victorine H.
AU - Bastiaansen, Barbara A. J.
AU - Hompes, Roel
AU - Bemelman, Willem A.
AU - Aalfs, Cora M.
AU - Bossuyt, Patrick M. M.
AU - Dekker, Evelien
N1 - Funding Information: DISCLOSURE: The following authors disclosed financial relationships: B. A. J. Bastiaansen: Speaker for Olympus, Tillotts Pharma AG, and Ovesco Endoscopy. R. Hompes: Research funding from Stryker; consultant and speaker for Applied Medical. W. A. Bemelman: Research funding from VIFOR; consultant and speaker for Takedo, Braun, and Johnson. E. Dekker: Consultant for Fujifilm, Olympus, GI Supply, PAION, and Ambu; speaker for Fujifilm, Olympus, GI Supply, PAION, Roche, Norgine, and Ipsen; equipment on loan from Fujifilm and Olympus; research funding from Fujifilm. All other authors disclosed no financial relationships. Funding Information: DISCLOSURE: The following authors disclosed financial relationships: B. A. J. Bastiaansen: Speaker for Olympus, Tillotts Pharma AG, and Ovesco Endoscopy. R. Hompes: Research funding from Stryker; consultant and speaker for Applied Medical. W. A. Bemelman: Research funding from VIFOR; consultant and speaker for Takedo, Braun, and Johnson. E. Dekker: Consultant for Fujifilm, Olympus, GI Supply, PAION, and Ambu; speaker for Fujifilm, Olympus, GI Supply, PAION, Roche, Norgine, and Ipsen; equipment on loan from Fujifilm and Olympus; research funding from Fujifilm. All other authors disclosed no financial relationships. Publisher Copyright: © 2023 American Society for Gastrointestinal Endoscopy
PY - 2023/1
Y1 - 2023/1
N2 - Background and Aims: Patients with familial adenomatous polyposis (FAP) undergo (procto)colectomy to prevent colorectal cancer from developing. Interestingly, after proctocolectomy with ileal pouch-anal anastomosis (IPAA), most patients develop adenomas in the pouch. This is not well described for patients with end ileostomy. We aimed to compare ileal adenoma development in patients with IPAA with those with end ileostomy. Methods: This historical cohort study included FAP patients with IPAA or end ileostomy who underwent surveillance endoscopies between 2001 and 2021. Primary outcomes were the proportion of patients with ileal adenomas, location of adenomas, and proportion of patients undergoing surgical excision of pouch/end ileostomy. Results: Overall, 144 patients with IPAA (n = 111) and end ileostomy (n = 33) were included. Five years after surgery, 15% of patients with IPAA had ileal adenomas versus 4% after ileostomy. At 10 years, these estimates were 48% versus 9% and at 20 years were 85% versus 43% (log-rank P <.001). Adenomas developed more often in the pouch body (95%) in the IPAA group and more often at the everted site of the ileostomy (77%) in the ileostomy group. Numbers for surgical excision of the pouch (n = 9) or ileostomy (n = 3) for polyposis or cancer were comparable. Taking into account potential confounders in a multivariable Cox regression analysis, having an IPAA was significantly associated with ileal adenoma development. Conclusions: After proctocolectomy, FAP patients with IPAA more often developed ileal adenomas than patients with end ileostomy. This could potentially affect long-term management, and patients with end ileostomy might benefit from less-frequent endoscopic surveillance.
AB - Background and Aims: Patients with familial adenomatous polyposis (FAP) undergo (procto)colectomy to prevent colorectal cancer from developing. Interestingly, after proctocolectomy with ileal pouch-anal anastomosis (IPAA), most patients develop adenomas in the pouch. This is not well described for patients with end ileostomy. We aimed to compare ileal adenoma development in patients with IPAA with those with end ileostomy. Methods: This historical cohort study included FAP patients with IPAA or end ileostomy who underwent surveillance endoscopies between 2001 and 2021. Primary outcomes were the proportion of patients with ileal adenomas, location of adenomas, and proportion of patients undergoing surgical excision of pouch/end ileostomy. Results: Overall, 144 patients with IPAA (n = 111) and end ileostomy (n = 33) were included. Five years after surgery, 15% of patients with IPAA had ileal adenomas versus 4% after ileostomy. At 10 years, these estimates were 48% versus 9% and at 20 years were 85% versus 43% (log-rank P <.001). Adenomas developed more often in the pouch body (95%) in the IPAA group and more often at the everted site of the ileostomy (77%) in the ileostomy group. Numbers for surgical excision of the pouch (n = 9) or ileostomy (n = 3) for polyposis or cancer were comparable. Taking into account potential confounders in a multivariable Cox regression analysis, having an IPAA was significantly associated with ileal adenoma development. Conclusions: After proctocolectomy, FAP patients with IPAA more often developed ileal adenomas than patients with end ileostomy. This could potentially affect long-term management, and patients with end ileostomy might benefit from less-frequent endoscopic surveillance.
UR - http://www.scopus.com/inward/record.url?scp=85141815645&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.gie.2022.08.031
DO - https://doi.org/10.1016/j.gie.2022.08.031
M3 - Article
C2 - 36029885
SN - 0016-5107
VL - 97
SP - 69-77.e1
JO - Gastrointestinal endoscopy
JF - Gastrointestinal endoscopy
IS - 1
ER -